|  Help  |  About  |  Contact Us

Publication : miR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer's disease.

First Author  Zong Y Year  2015
Journal  Brain Res Volume  1624
Pages  95-102 PubMed ID  26212654
Mgi Jnum  J:316467 Mgi Id  MGI:6837786
Doi  10.1016/j.brainres.2015.07.022 Citation  Zong Y, et al. (2015) miR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer's disease. Brain Res 1624:95-102
abstractText  The microRNA-29 family (miRNA-29s) has three mature members, miR-29a, miR-29b and miR-29c, which have been implicated in the regulation of the pathogenesis of Alzheimer's disease (AD). The miR-29 family members exhibit differential regulation in various diseases and different subcellular distribution. In the present study, we initially investigated differential expression of miR-29c in the hippocampus and the frontal cortex of the young APPswe/PSDeltaE9 mouse brain, accompanied by inverse expression of neurone navigator 3 (NAV3), a regulator of axon guidance. We observed that miR-29c directly mediated downregulation of NAV3 protein expression in vitro. The mouse NAV3 mRNA has a functional miR-29c binding site in the 3' UTR, which localized in the position between 830-836 bp of 3'UTR region, slightly different from human NAV3 mRNA binding site. These observations suggest that miR-29c may be involved in neurodegenerative processes by regulating NAV3 expression in the young AD mouse.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression